Cell>Point is developing a cancer diagnostic tool and therapeutic agent using a sugar molecule called Glucosamine. The diagnostic agent will use an isotope that will let doctors image cancer using a SPECT camera while the therapeutic agent will deliver a chemotherapy drug directly to a tumor. The company says the tools are meant to function together and provide data on whether the chemotherapy is working, which could allow for about $20,000 savings for each lung cancer patient.

Full Story:
KUSA-TV (Denver)

Related Summaries